NYTimes Science Times (& More): A dynamic leader of 21st century med. research; nukes & health & profits in Japan; social and web media “big data”; transparent (but dead) brains…
Tuesday, October 11th, 2011
At first glance, there is little apparent reason that a paean to a medical center administrator – one that shouts “puff piece” from the get-go – should lead today’s NYT science section. And not all that misgiving evaporates before the last graf. But Denise Grady‘s profile of the chancellor of the UC San Francisco Medical Center, who was a practicing physician before she jumped into cancer drug invetnion at Genentech, is mesmerizing. Mostly becuase, sort of like the life bios of the late Steve Jobs left me and probably you exhausted, it is bracing just to imagine so much energy, imagination, and force of will all in one person. Except, it appears, that this lady is a lot easier to get along with than was the driven, demanding Mr. Jobs.
Maybe it’s because I once covered that medical center, 20+ years ago, and even then thought it was very near the top of the heap and didn’t have to feel second-class in the company of the Mayo Clinic, that the underlying thesis that UCSF is not already a shining facility seems odd. More important is the profile and the vision it offers of the future of medical education in general that will keep most readers all the way through to the end.
Before listing a few other Scitimes stories to look at, one tangent. In other sections are two Japan nuke stories by one reporter:
- Hiroko Tabuchi: In Japan, a Long-Term Study on Radiation Leaks’ Effects ; A solid main news section account of the correct move in Japan to collect long term epidemiological data on youngsters from around Fukushima. One would however like to have seen reference (perhaps NYT has reported this before) to any similar study of the workers who risked a great deal to be on site in the first several weeks after the mass meltdowns.
- Hiroko Tabuchi (Biz section) Japan Courts the Money in Reactors ; Another solid piece on the marketing of Japan’s nuclear technology to other nations, and explicitly on its irony in the wake of Fukishima. Eyebrows may go up at this line, however: “While Fukishima Daiichi could not withstand the magnitude 9 quake and the tsunami that revaged much of Japan’s northest cost in March...” . That’s arguable whether the quake alone would have done much more than force a shutdown, with little public hazard. I recently heard a comprehensive review of the plant’s catastrophic systemic failure. It places essentially all the blame for its abysmal performance on failure by its builders and by government overseers to heed the clear geological evidence that the region periodically sees immense tsunamis – more than twice the height of the berm. See the video of a talk by Berkeley Nat’l Lab veteran nuke safety analyst Robert Budnitz. It goes through it woeful by woeful moment. Earthquakes can be bad for reactors. But writers should be careful not to lump the quake’s seismic waves, and the later sea wave as equal, proximate causes for Fukushima. Nearly ALL the tragedy from the earthquake was not from the shaking, but the resulting wedge of ocean that plowed relentlessly onshore. Japan is pretty ready for earthquakes. But it didn’t think the problem all the way through.
Other Science Times headlines of note:
- John Markoff: Government Aims to Build a ‘Date Eye in the Sky’ ; Fuel for paranoia here – the kind that might mean somebody really is watching you. Markoff joins media interest recently in the info buried in the masses of data reflected in crowd info, whether from wiretaps or the topics on Twitter or the entries in search engines, and more. All that’s left out is surveillance cameras – but we have TV’s new and interesting program, Person of Interest, to (fictionally) fill that hole.
- 2 stories on one issue, Gardiner Harris: Outside Panel Backs Prostate Test Advisory ; and Tara Parker-Pope: Prostate Test Finding Leaves a Swirl of Confusion ;
- David Tuller: Questions on Tactic to Prevent H.I.V. ; Fine look, with no answers but that would be too much to expect, at spreading interest in use of costly and somewhat scarce anti-retroviral drugs as an anti-HIV prophylactic for healthy people, mostly men.
- Felicity Barringer: Ban Hybrids From the Fast Lane, and Everyone Slows Down ; Or, the law of unexpected consequences kicks in again.
As usual lots more. Whole Section;
- Charlie Petit